DNMT3A and acute myeloid leukemia: In our cases presenting with a chronic clinical phenotype, we found a low burden of somatic mutations involving TET2, DNMT3A, HRAS, and CEBPA. Notably, five and four variants affected the RUNX1 gene in our AML case no. 13 and no. 14, respectively.